Home Data Calendar Blog

LYEL

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Common Stock Value 0.030.030.030.030.030.030.030.020.020.02NA0.00NANA
Weighted Average Number Of Diluted Shares Outstanding 251.32250.20249.59NA248.32246.31244.18NA239.3842.7117.27NANANA
Weighted Average Number Of Shares Outstanding Basic 251.32250.20249.59NA248.32246.31244.18NA239.3842.7117.27NANANA
Earnings Per Share Basic -0.20-0.26-0.27-0.03-0.28-0.15-0.28-0.18-0.20-1.47-3.19NANANA
Earnings Per Share Diluted -0.20-0.26-0.27-0.03-0.28-0.15-0.28-0.18-0.20-1.47-3.19NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Revenues 0.030.030.0748.390.0035.740.552.822.752.632.442.311.073.12
Operating Expenses 59.0665.9362.6263.1766.4473.0069.1350.3651.9265.3357.8141.8437.91105.68
Research And Development Expense 43.8547.4744.6338.0341.6143.7235.8319.2931.4346.4541.5335.0924.5097.15
General And Administrative Expense 15.5119.0319.2826.3526.0830.4534.4231.8721.2419.1116.8314.8713.579.56
Operating Income Loss -59.04-65.91-62.56-14.78-66.44-37.26-68.58-47.54-49.16-62.71-55.37-39.52-36.84-102.57
Interest Income Expense Nonoperating Net 6.615.264.503.452.250.950.400.320.270.220.35NANANA
Allocated Share Based Compensation Expense 10.5214.2213.8818.3619.1222.4122.0321.1813.0415.2512.7312.979.757.27
Other Comprehensive Income Loss Net Of Tax 1.201.503.722.40-1.65-1.75-4.98-1.56-0.14-0.09-0.09-0.34-0.600.10
Net Income Loss -50.85-63.89-66.96-8.40-70.25-36.32-68.14-83.71-48.88-62.59-55.04-38.86-35.72-100.66
Comprehensive Income Net Of Tax -49.66-62.39-63.24-6.00-71.90-38.07-73.12-85.26-49.01-62.69-55.14-39.19-36.32-100.55

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Assets 794.99835.35880.45937.56977.271021.671072.101127.411198.331229.87NA908.28NANA
Liabilities 97.4298.5096.62104.31157.24153.63190.85197.62211.86207.91NA189.84NANA
Liabilities And Stockholders Equity 794.99835.35880.45937.56977.271021.671072.101127.411198.331229.87NA908.28NANA
Stockholders Equity 697.57736.86783.83833.25820.03868.04881.25929.79986.471021.96-334.05-292.53-266.64-240.11

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Assets Current 586.85606.41624.40651.29659.75666.78625.71626.29631.15834.84NA617.55NANA
Cash And Cash Equivalents At Carrying Value 286.21224.37109.43123.55116.31205.74222.60293.83393.50564.44244.37140.41134.41245.95
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 286.50224.65109.71123.83116.59206.02222.88294.29393.97564.91244.84140.87134.88246.42
Marketable Securities Current 289.22371.38503.34516.60531.82449.82391.32320.97225.42260.08NA472.21NANA
Prepaid Expense And Other Assets Current 11.4210.6611.6311.1411.6111.2111.7911.4912.2310.32NA4.93NANA
Equity Securities Fv Ni NANANANANA1.081.091.07NANANA1.32NANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Property Plant And Equipment Gross NANANA155.41NANANA134.61NANANA82.15NANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NANANA32.38NANANA14.51NANANA5.10NANA
Property Plant And Equipment Net 108.10113.68118.60123.02125.73127.56125.71120.10115.86109.64NA77.05NANA
Other Assets Noncurrent 4.424.524.604.682.913.713.573.482.672.79NA2.77NANA
Equity Securities Fv Ni NANANANANA1.081.091.07NANANA1.32NANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Liabilities Current 35.0634.3930.8037.0351.2250.2941.0546.7459.2863.66NA49.28NANA
Accounts Payable Current 4.375.805.733.924.794.256.513.213.534.86NA9.40NANA
Other Accrued Liabilities Current NANANA2.35NANANA1.47NANANA0.66NANA
Contract With Customer Liability Current NANANANA11.1915.436.224.995.588.23NA6.09NANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Other Liabilities Noncurrent 3.783.894.004.114.234.344.454.575.010.90NA0.53NANA
Operating Lease Liability Noncurrent 58.5860.2261.8363.1764.6466.0767.4766.6565.6861.47NA50.96NANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Stockholders Equity 697.57736.86783.83833.25820.03868.04881.25929.79986.471021.96-334.05-292.53-266.64-240.11
Common Stock Value 0.030.030.030.030.030.030.030.020.020.02NA0.00NANA
Additional Paid In Capital 1647.911637.541622.121608.311589.081565.201540.331515.75NANANA41.36NANA
Retained Earnings Accumulated Deficit -949.18-898.33-834.44-767.48-759.08-688.83-652.51-584.36-500.66-451.78NA-334.14NANA
Accumulated Other Comprehensive Income Loss Net Of Tax -1.18-2.38-3.88-7.60-10.00-8.35-6.60-1.62-0.070.07NA0.26NANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 10.5214.2213.8818.3619.1222.4122.0321.1813.0415.2512.7312.979.787.27

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Net Cash Provided By Used In Operating Activities -37.69-39.16-46.21-40.27-37.10-44.33-47.85-33.17-25.53-33.95-33.60-26.73-21.63NA
Net Cash Provided By Used In Investing Activities 99.67152.9132.1546.65-57.0925.02-26.12-73.90-144.87-39.47136.6832.39-89.94NA
Net Cash Provided By Used In Financing Activities -0.141.20-0.070.864.762.462.567.40-0.53393.490.880.340.04NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Net Cash Provided By Used In Operating Activities -37.69-39.16-46.21-40.27-37.10-44.33-47.85-33.17-25.53-33.95-33.60-26.73-21.63NA
Net Income Loss -50.85-63.89-66.96-8.40-70.25-36.32-68.14-83.71-48.88-62.59-55.04-38.86-35.72-100.66
Depreciation Depletion And Amortization 5.105.065.035.044.624.174.194.574.093.011.961.451.10NA
Increase Decrease In Accounts Payable -1.410.382.07-0.530.02-1.772.940.10-0.990.350.630.34-0.29NA
Share Based Compensation 10.5214.2213.8818.3619.1222.4122.0321.1813.0415.2512.7312.979.75NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Net Cash Provided By Used In Investing Activities 99.67152.9132.1546.65-57.0925.02-26.12-73.90-144.87-39.47136.6832.39-89.94NA
Payments To Acquire Property Plant And Equipment 0.200.931.534.582.797.179.7310.2711.6024.4519.1924.8812.64NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Net Cash Provided By Used In Financing Activities -0.141.20-0.070.864.762.462.567.40-0.53393.490.880.340.04NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Revenues 0.030.030.0748.390.0035.740.552.822.752.632.442.311.073.12
Glaxo Smith Kline Intellectual Property No5 Limited And Glaxo Group Limited, Adjustment To Revenue Related To Change In Estimate, Collaborative Arrangement Transaction With Party To Collaborative Arrangement NANANA48.300.0035.30NANANANANANANANA
Glaxo Smith Kline Intellectual Property No5 Limited And Glaxo Group Limited, Adjustment To Revenue Related To Change In Estimate, Collaborative Arrangement Transaction With Party To Collaborative Arrangement NANANA48.300.0035.30NANANANANANANANA
GSK, Related Party NANANANA0.0035.70NANANANANANANANA
Glaxo Smith Kline Intellectual Property No5 Limited And Glaxo Group Limited, Collaborative Arrangement Transaction With Party To Collaborative Arrangement NANANA48.400.0035.700.602.802.602.602.40NANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Balance Sheet
Liabilities Current
Assets
Equity Securities Fv Ni
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Liabilities Current
Current Liabilities
Other Accrued Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:ResearchAndDevelopmentExpense
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
(None, 'us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangement')
Research And Development Expenseus-gaap: Counterparty Name, us-gaap: Type Of Arrangement
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Financial Instrument
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument
(None,)
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components